Literature DB >> 27165419

The Prognostic Role of Ventilatory Inefficiency and Exercise Capacity in Idiopathic Pulmonary Fibrosis.

Baruch Vainshelboim1, Jose Oliveira2, Benjamin Daniel Fox3, Mordechai Reuven Kramer3.   

Abstract

BACKGROUND: Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, and fatal interstitial lung disease associated with poor prognosis and limited effective treatment options. Reliable predictors of outcome in daily clinical practice are needed to determine high-risk patients for urgent lung transplantation referral. This study aimed to identify practical prognostic predictors of mortality using cardiopulmonary exercise testing (CPET) in IPF subjects.
METHODS: Thirty-four subjects with IPF (22 men and 12 women), median age 68 (range 50-81) y were prospectively studied. At baseline, all subjects were assessed with CPET and were followed up for 40 months from baseline. Receiver operating characteristic curve analysis was conducted to determine cut-off points of CPET variables for mortality, Cox regression analysis for survival using a log-rank test, and hazard ratio for death using a Wald test.
RESULTS: Peak work rate <62 watts (P = .005), peak V̇O2 ≤13.8 mL/kg/min (P = .031), tidal volume reserve ≤0.48 L/breath (P = .010), minute ventilation to carbon dioxide (V̇E)/V̇CO2 ) ratio at the anaerobic threshold >34 (P = .02), and V̇E)/V̇O2 nadir >34 (P = .002) were detected as cut-off points associated with mortality. Non-survivor subjects were characterized by higher dyspnea levels, the presence of pulmonary hypertension assessed by echocardiography, pronounced inefficient ventilatory pattern, lower exercise capacity, and more severe desaturation during physical exertion. By the end of the study, 11 subjects (7 women and 4 men) died. Overall mean survival was 60%, 33.7 months (95% CI 30.2-37.2).
CONCLUSIONS: This study provides simple, practical, and novel cut-off points for CPET as predictors of prognosis to identify high-risk IPF subjects. Impairment in exercise capacity and abnormal ventilatory responses during CPET were associated with poorer survival in IPF subjects. The findings suggest considering the use of CPET for IPF risk stratification and prediction of prognosis. (ClinicalTrials.gov registration NCT01499745.).
Copyright © 2016 by Daedalus Enterprises.

Entities:  

Keywords:  cardiopulmonary exercise testing; exercise intolerance; prognostic predictors; survival; ventilatory response

Mesh:

Year:  2016        PMID: 27165419     DOI: 10.4187/respcare.04471

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  11 in total

1.  Ventilatory efficiency slope as a predictor of suitability for surgery in chronic obstructive pulmonary disease patients with lung cancer.

Authors:  Mathew Suji Eapen; Ravneet Grover; Kiran Ahuja; Andrew Williams; Sukhwinder Singh Sohal
Journal:  Ann Transl Med       Date:  2016-08

2.  Decreased peak expiratory flow rate associated with mortality in idiopathic pulmonary fibrosis: A preliminary report.

Authors:  Kohei Fujita; Hirotsugu Ohkubo; Akiko Nakano; Norihisa Takeda; Kensuke Fukumitsu; Satoshi Fukuda; Yoshihiro Kanemitsu; Takehiro Uemura; Tomoko Tajiri; Ken Maeno; Yutaka Ito; Tetsuya Oguri; Yoshiyuki Ozawa; Takayuki Murase; Akio Niimi
Journal:  Chron Respir Dis       Date:  2022 Jan-Dec       Impact factor: 3.115

3.  8-Foot-Up-and-Go Test is Associated with Hospitalizations and Mortality in Idiopathic Pulmonary Fibrosis: A Prospective Pilot Study.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Jonathan Myers; Avraham Unterman; Shimon Izhakian; Jose Oliveira
Journal:  Lung       Date:  2019-01-02       Impact factor: 2.584

4.  Cardiopulmonary Exercise Testing Allows Discrimination Between Idiopathic Non-specific Interstitial Pneumonia and Idiopathic Pulmonary Fibrosis in Mild to Moderate Stages of the Disease.

Authors:  Lars Hagmeyer; Simon Herkenrath; Norbert Anduleit; Marcel Treml; Winfried Randerath
Journal:  Lung       Date:  2019-11-01       Impact factor: 2.584

Review 5.  Ventilatory efficiency slope is associated with cardiopulmonary complications after thoracoscopic anatomical lung resection.

Authors:  Benoît Bédat; Evangelos Koliakos; Marco S Demarchi; Jean Perentes; Marc-Joseph Licker; Frédéric Triponez; Thorsten Krueger; Wolfram Karenovics; Michel Gonzalez
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-06-15

6.  Cardiopulmonary exercise testing and prognosis in patients with systemic sclerosis without baseline pulmonary hypertension: a prospective cohort study.

Authors:  Vasiliki-Kalliopi Bournia; Anastasios Kallianos; Stylianos Panopoulos; Elias Gialafos; Lemonia Velentza; Panayiotis G Vlachoyiannopoulos; Petros P Sfikakis; Georgia Trakada
Journal:  Rheumatol Int       Date:  2021-06-29       Impact factor: 2.631

7.  Physical Activity and Exertional Desaturation Are Associated with Mortality in Idiopathic Pulmonary Fibrosis.

Authors:  Baruch Vainshelboim; Mordechai Reuven Kramer; Shimon Izhakian; Ricardo M Lima; Jose Oliveira
Journal:  J Clin Med       Date:  2016-08-18       Impact factor: 4.241

8.  Sex-specific cardiopulmonary exercise testing indices to estimate the severity of inoperable chronic thromboembolic pulmonary hypertension.

Authors:  Tian-Xiang Chen; Bigyan Pudasaini; Jian Guo; Su-Gang Gong; Rong Jiang; Lan Wang; Qin-Hua Zhao; Wen-Hui Wu; Ping Yuan; Jin-Ming Liu
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-01-26

9.  Comparison of CPI and GAP models in patients with idiopathic pulmonary fibrosis: a nationwide cohort study.

Authors:  Sang Hoon Lee; Jong Sun Park; Song Yee Kim; Dong Soon Kim; Young Whan Kim; Man Pyo Chung; Soo Taek Uh; Choon Sik Park; Sung Woo Park; Sung Hwan Jeong; Yong Bum Park; Hong Lyeol Lee; Jong Wook Shin; Eun Joo Lee; Jin Hwa Lee; Yangin Jegal; Hyun Kyung Lee; Yong Hyun Kim; Jin Woo Song; Moo Suk Park
Journal:  Sci Rep       Date:  2018-03-19       Impact factor: 4.379

10.  Value of Cardiopulmonary Exercise Testing in Prognostic Assessment of Patients with Interstitial Lung Diseases.

Authors:  Beate Stubbe; Till Ittermann; Anita Grieger; Charlotte Walther; Sven Gläser; Ralf Ewert
Journal:  J Clin Med       Date:  2022-03-14       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.